Investor Alley Inc.

Harbor Island Development Corp and Roche Holding AG News: (OTC:HIDC), (OTC:RHHBY)

 

New York, NY -- (ReleaseWire) -- 04/16/2013 --Harbor Island Development Corp. (OTC:HIDC) through its wholly owned subsidiary BrandSeed Media Services LLC., a multi-channel direct marketing service provider, today announced that the Company has signed a print marketing agreement with Merlin Technologies, the manufacturer of GeeWhiz®, a patented incontinence device currently sold nationwide through primary care physicians, hospitals and direct to the consumer.

The GeeWhiz® Incontinence Management Device (IMD) is also known as an external male condom catheter. Protected by 5 issued and other U.S. patents pending, and Medicare billing approved, GeeWhiz is a medical device for men with urinary incontinence, an involuntary loss of bladder or bowel control. According to International Continence Society, urinary incontinence affects 200 million people worldwide of which one-third are men.

BrandSeed’s team brings years of expertise creating direct marketing platforms across consumer verticals that strive to drive the lowest customer acquisition costs and maximum customer lifetime value.

Find out where HIDC could be headed by getting the free and full trend analysis report here: http://www.wallstreetscoop.net/market-scan/?symbol=HIDC

Roche Holding AG (OTCQX: RHHBY) and Isis Pharmaceuticals, Inc (ISIS) announced, last week, that they have formed an alliance to develop treatments for Huntington's disease (HD) based on Isis' antisense oligonucleotide (ASO) technology.

This alliance combines Isis' antisense expertise with Roche's scientific expertise in developing neurodegenerative therapeutics. In addition, Isis and Roche will be collaborating to combine Isis' ASOs and Roche's proprietary "brain shuttle" program with the objective of increasing the brain penetration of ASOs with systemic administration.

Initially, research will focus on Isis' lead drug candidate that blocks production of all forms of the huntingtin (HTT) protein, the protein responsible for HD and thus has the potential to treat all HD patients.

Find out more on RHHBY here:
http://www.wallstreetscoop.net/market-scan/?symbol=RHHBY

About WallStreetScoop.net
WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure
WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: http://www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009